Global Ischemic Stroke Drugs Market Research Report 2023

Report ID: 1975186 | Published Date: Oct 2024 | No. of Page: 89 | Base Year: 2023 | Rating: 4.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Ischemic Stroke Drugs Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Tissue Plasminogen Activator
        1.2.3 Anticoagulant
        1.2.4 Antiplatelet
        1.2.5 Antihypertensive
        1.2.6 Others
    1.3 Market by Application
        1.3.1 Global Ischemic Stroke Drugs Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Ambulatory Surgical Centers
        1.3.5 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Ischemic Stroke Drugs Market Perspective (2017-2028)
    2.2 Ischemic Stroke Drugs Growth Trends by Region
        2.2.1 Ischemic Stroke Drugs Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Ischemic Stroke Drugs Historic Market Size by Region (2017-2022)
        2.2.3 Ischemic Stroke Drugs Forecasted Market Size by Region (2023-2028)
    2.3 Ischemic Stroke Drugs Market Dynamics
        2.3.1 Ischemic Stroke Drugs Industry Trends
        2.3.2 Ischemic Stroke Drugs Market Drivers
        2.3.3 Ischemic Stroke Drugs Market Challenges
        2.3.4 Ischemic Stroke Drugs Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Ischemic Stroke Drugs Players by Revenue
        3.1.1 Global Top Ischemic Stroke Drugs Players by Revenue (2017-2022)
        3.1.2 Global Ischemic Stroke Drugs Revenue Market Share by Players (2017-2022)
    3.2 Global Ischemic Stroke Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Ischemic Stroke Drugs Revenue
    3.4 Global Ischemic Stroke Drugs Market Concentration Ratio
        3.4.1 Global Ischemic Stroke Drugs Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Ischemic Stroke Drugs Revenue in 2021
    3.5 Ischemic Stroke Drugs Key Players Head office and Area Served
    3.6 Key Players Ischemic Stroke Drugs Product Solution and Service
    3.7 Date of Enter into Ischemic Stroke Drugs Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Ischemic Stroke Drugs Breakdown Data by Type
    4.1 Global Ischemic Stroke Drugs Historic Market Size by Type (2017-2022)
    4.2 Global Ischemic Stroke Drugs Forecasted Market Size by Type (2023-2028)
5 Ischemic Stroke Drugs Breakdown Data by Application
    5.1 Global Ischemic Stroke Drugs Historic Market Size by Application (2017-2022)
    5.2 Global Ischemic Stroke Drugs Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Ischemic Stroke Drugs Market Size (2017-2028)
    6.2 North America Ischemic Stroke Drugs Market Size by Country (2017-2022)
    6.3 North America Ischemic Stroke Drugs Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Ischemic Stroke Drugs Market Size (2017-2028)
    7.2 Europe Ischemic Stroke Drugs Market Size by Country (2017-2022)
    7.3 Europe Ischemic Stroke Drugs Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Ischemic Stroke Drugs Market Size (2017-2028)
    8.2 Asia-Pacific Ischemic Stroke Drugs Market Size by Country (2017-2022)
    8.3 Asia-Pacific Ischemic Stroke Drugs Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Ischemic Stroke Drugs Market Size (2017-2028)
    9.2 Latin America Ischemic Stroke Drugs Market Size by Country (2017-2022)
    9.3 Latin America Ischemic Stroke Drugs Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Ischemic Stroke Drugs Market Size (2017-2028)
    10.2 Middle East & Africa Ischemic Stroke Drugs Market Size by Country (2017-2022)
    10.3 Middle East & Africa Ischemic Stroke Drugs Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Pfizer
        11.1.1 Pfizer Company Detail
        11.1.2 Pfizer Business Overview
        11.1.3 Pfizer Ischemic Stroke Drugs Introduction
        11.1.4 Pfizer Revenue in Ischemic Stroke Drugs Business (2017-2022)
        11.1.5 Pfizer Recent Development
    11.2 Merck
        11.2.1 Merck Company Detail
        11.2.2 Merck Business Overview
        11.2.3 Merck Ischemic Stroke Drugs Introduction
        11.2.4 Merck Revenue in Ischemic Stroke Drugs Business (2017-2022)
        11.2.5 Merck Recent Development
    11.3 Boehringer Ingelheim
        11.3.1 Boehringer Ingelheim Company Detail
        11.3.2 Boehringer Ingelheim Business Overview
        11.3.3 Boehringer Ingelheim Ischemic Stroke Drugs Introduction
        11.3.4 Boehringer Ingelheim Revenue in Ischemic Stroke Drugs Business (2017-2022)
        11.3.5 Boehringer Ingelheim Recent Development
    11.4 Sanofi
        11.4.1 Sanofi Company Detail
        11.4.2 Sanofi Business Overview
        11.4.3 Sanofi Ischemic Stroke Drugs Introduction
        11.4.4 Sanofi Revenue in Ischemic Stroke Drugs Business (2017-2022)
        11.4.5 Sanofi Recent Development
    11.5 Johnson & Johnson
        11.5.1 Johnson & Johnson Company Detail
        11.5.2 Johnson & Johnson Business Overview
        11.5.3 Johnson & Johnson Ischemic Stroke Drugs Introduction
        11.5.4 Johnson & Johnson Revenue in Ischemic Stroke Drugs Business (2017-2022)
        11.5.5 Johnson & Johnson Recent Development
    11.6 Bayer
        11.6.1 Bayer Company Detail
        11.6.2 Bayer Business Overview
        11.6.3 Bayer Ischemic Stroke Drugs Introduction
        11.6.4 Bayer Revenue in Ischemic Stroke Drugs Business (2017-2022)
        11.6.5 Bayer Recent Development
    11.7 Biogen
        11.7.1 Biogen Company Detail
        11.7.2 Biogen Business Overview
        11.7.3 Biogen Ischemic Stroke Drugs Introduction
        11.7.4 Biogen Revenue in Ischemic Stroke Drugs Business (2017-2022)
        11.7.5 Biogen Recent Development
    11.8 Abbott Laboratories
        11.8.1 Abbott Laboratories Company Detail
        11.8.2 Abbott Laboratories Business Overview
        11.8.3 Abbott Laboratories Ischemic Stroke Drugs Introduction
        11.8.4 Abbott Laboratories Revenue in Ischemic Stroke Drugs Business (2017-2022)
        11.8.5 Abbott Laboratories Recent Development
    11.9 Genentech
        11.9.1 Genentech Company Detail
        11.9.2 Genentech Business Overview
        11.9.3 Genentech Ischemic Stroke Drugs Introduction
        11.9.4 Genentech Revenue in Ischemic Stroke Drugs Business (2017-2022)
        11.9.5 Genentech Recent Development
    11.10 Daiichi Sankyo
        11.10.1 Daiichi Sankyo Company Detail
        11.10.2 Daiichi Sankyo Business Overview
        11.10.3 Daiichi Sankyo Ischemic Stroke Drugs Introduction
        11.10.4 Daiichi Sankyo Revenue in Ischemic Stroke Drugs Business (2017-2022)
        11.10.5 Daiichi Sankyo Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Ischemic Stroke Drugs Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Tissue Plasminogen Activator
    Table 3. Key Players of Anticoagulant
    Table 4. Key Players of Antiplatelet
    Table 5. Key Players of Antihypertensive
    Table 6. Key Players of Others
    Table 7. Global Ischemic Stroke Drugs Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Ischemic Stroke Drugs Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 9. Global Ischemic Stroke Drugs Market Size by Region (2017-2022) & (US$ Million)
    Table 10. Global Ischemic Stroke Drugs Market Share by Region (2017-2022)
    Table 11. Global Ischemic Stroke Drugs Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 12. Global Ischemic Stroke Drugs Market Share by Region (2023-2028)
    Table 13. Ischemic Stroke Drugs Market Trends
    Table 14. Ischemic Stroke Drugs Market Drivers
    Table 15. Ischemic Stroke Drugs Market Challenges
    Table 16. Ischemic Stroke Drugs Market Restraints
    Table 17. Global Ischemic Stroke Drugs Revenue by Players (2017-2022) & (US$ Million)
    Table 18. Global Ischemic Stroke Drugs Market Share by Players (2017-2022)
    Table 19. Global Top Ischemic Stroke Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ischemic Stroke Drugs as of 2021)
    Table 20. Ranking of Global Top Ischemic Stroke Drugs Companies by Revenue (US$ Million) in 2021
    Table 21. Global 5 Largest Players Market Share by Ischemic Stroke Drugs Revenue (CR5 and HHI) & (2017-2022)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Ischemic Stroke Drugs Product Solution and Service
    Table 24. Date of Enter into Ischemic Stroke Drugs Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Ischemic Stroke Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 27. Global Ischemic Stroke Drugs Revenue Market Share by Type (2017-2022)
    Table 28. Global Ischemic Stroke Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 29. Global Ischemic Stroke Drugs Revenue Market Share by Type (2023-2028)
    Table 30. Global Ischemic Stroke Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 31. Global Ischemic Stroke Drugs Revenue Market Share by Application (2017-2022)
    Table 32. Global Ischemic Stroke Drugs Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 33. Global Ischemic Stroke Drugs Revenue Market Share by Application (2023-2028)
    Table 34. North America Ischemic Stroke Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 35. North America Ischemic Stroke Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 36. Europe Ischemic Stroke Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 37. Europe Ischemic Stroke Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 38. Asia-Pacific Ischemic Stroke Drugs Market Size by Region (2017-2022) & (US$ Million)
    Table 39. Asia-Pacific Ischemic Stroke Drugs Market Size by Region (2023-2028) & (US$ Million)
    Table 40. Latin America Ischemic Stroke Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 41. Latin America Ischemic Stroke Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 42. Middle East & Africa Ischemic Stroke Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 43. Middle East & Africa Ischemic Stroke Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 44. Pfizer Company Detail
    Table 45. Pfizer Business Overview
    Table 46. Pfizer Ischemic Stroke Drugs Product
    Table 47. Pfizer Revenue in Ischemic Stroke Drugs Business (2017-2022) & (US$ Million)
    Table 48. Pfizer Recent Development
    Table 49. Merck Company Detail
    Table 50. Merck Business Overview
    Table 51. Merck Ischemic Stroke Drugs Product
    Table 52. Merck Revenue in Ischemic Stroke Drugs Business (2017-2022) & (US$ Million)
    Table 53. Merck Recent Development
    Table 54. Boehringer Ingelheim Company Detail
    Table 55. Boehringer Ingelheim Business Overview
    Table 56. Boehringer Ingelheim Ischemic Stroke Drugs Product
    Table 57. Boehringer Ingelheim Revenue in Ischemic Stroke Drugs Business (2017-2022) & (US$ Million)
    Table 58. Boehringer Ingelheim Recent Development
    Table 59. Sanofi Company Detail
    Table 60. Sanofi Business Overview
    Table 61. Sanofi Ischemic Stroke Drugs Product
    Table 62. Sanofi Revenue in Ischemic Stroke Drugs Business (2017-2022) & (US$ Million)
    Table 63. Sanofi Recent Development
    Table 64. Johnson & Johnson Company Detail
    Table 65. Johnson & Johnson Business Overview
    Table 66. Johnson & Johnson Ischemic Stroke Drugs Product
    Table 67. Johnson & Johnson Revenue in Ischemic Stroke Drugs Business (2017-2022) & (US$ Million)
    Table 68. Johnson & Johnson Recent Development
    Table 69. Bayer Company Detail
    Table 70. Bayer Business Overview
    Table 71. Bayer Ischemic Stroke Drugs Product
    Table 72. Bayer Revenue in Ischemic Stroke Drugs Business (2017-2022) & (US$ Million)
    Table 73. Bayer Recent Development
    Table 74. Biogen Company Detail
    Table 75. Biogen Business Overview
    Table 76. Biogen Ischemic Stroke Drugs Product
    Table 77. Biogen Revenue in Ischemic Stroke Drugs Business (2017-2022) & (US$ Million)
    Table 78. Biogen Recent Development
    Table 79. Abbott Laboratories Company Detail
    Table 80. Abbott Laboratories Business Overview
    Table 81. Abbott Laboratories Ischemic Stroke Drugs Product
    Table 82. Abbott Laboratories Revenue in Ischemic Stroke Drugs Business (2017-2022) & (US$ Million)
    Table 83. Abbott Laboratories Recent Development
    Table 84. Genentech Company Detail
    Table 85. Genentech Business Overview
    Table 86. Genentech Ischemic Stroke Drugs Product
    Table 87. Genentech Revenue in Ischemic Stroke Drugs Business (2017-2022) & (US$ Million)
    Table 88. Genentech Recent Development
    Table 89. Daiichi Sankyo Company Detail
    Table 90. Daiichi Sankyo Business Overview
    Table 91. Daiichi Sankyo Ischemic Stroke Drugs Product
    Table 92. Daiichi Sankyo Revenue in Ischemic Stroke Drugs Business (2017-2022) & (US$ Million)
    Table 93. Daiichi Sankyo Recent Development
    Table 94. Research Programs/Design for This Report
    Table 95. Key Data Information from Secondary Sources
    Table 96. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Ischemic Stroke Drugs Market Share by Type: 2021 VS 2028
    Figure 2. Tissue Plasminogen Activator Features
    Figure 3. Anticoagulant Features
    Figure 4. Antiplatelet Features
    Figure 5. Antihypertensive Features
    Figure 6. Others Features
    Figure 7. Global Ischemic Stroke Drugs Market Share by Application in 2021 & 2028
    Figure 8. Hospitals Case Studies
    Figure 9. Clinics Case Studies
    Figure 10. Ambulatory Surgical Centers Case Studies
    Figure 11. Others Case Studies
    Figure 12. Ischemic Stroke Drugs Report Years Considered
    Figure 13. Global Ischemic Stroke Drugs Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 14. Global Ischemic Stroke Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 15. Global Ischemic Stroke Drugs Market Share by Region: 2021 VS 2028
    Figure 16. Global Ischemic Stroke Drugs Market Share by Players in 2021
    Figure 17. Global Top Ischemic Stroke Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ischemic Stroke Drugs as of 2021)
    Figure 18. The Top 10 and 5 Players Market Share by Ischemic Stroke Drugs Revenue in 2021
    Figure 19. North America Ischemic Stroke Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. North America Ischemic Stroke Drugs Market Share by Country (2017-2028)
    Figure 21. United States Ischemic Stroke Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Canada Ischemic Stroke Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe Ischemic Stroke Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Europe Ischemic Stroke Drugs Market Share by Country (2017-2028)
    Figure 25. Germany Ischemic Stroke Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. France Ischemic Stroke Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. U.K. Ischemic Stroke Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Italy Ischemic Stroke Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Russia Ischemic Stroke Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Nordic Countries Ischemic Stroke Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific Ischemic Stroke Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Asia-Pacific Ischemic Stroke Drugs Market Share by Region (2017-2028)
    Figure 33. China Ischemic Stroke Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Japan Ischemic Stroke Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. South Korea Ischemic Stroke Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Southeast Asia Ischemic Stroke Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. India Ischemic Stroke Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Australia Ischemic Stroke Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Latin America Ischemic Stroke Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Latin America Ischemic Stroke Drugs Market Share by Country (2017-2028)
    Figure 41. Mexico Ischemic Stroke Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Brazil Ischemic Stroke Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Middle East & Africa Ischemic Stroke Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Middle East & Africa Ischemic Stroke Drugs Market Share by Country (2017-2028)
    Figure 45. Turkey Ischemic Stroke Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Saudi Arabia Ischemic Stroke Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Pfizer Revenue Growth Rate in Ischemic Stroke Drugs Business (2017-2022)
    Figure 48. Merck Revenue Growth Rate in Ischemic Stroke Drugs Business (2017-2022)
    Figure 49. Boehringer Ingelheim Revenue Growth Rate in Ischemic Stroke Drugs Business (2017-2022)
    Figure 50. Sanofi Revenue Growth Rate in Ischemic Stroke Drugs Business (2017-2022)
    Figure 51. Johnson & Johnson Revenue Growth Rate in Ischemic Stroke Drugs Business (2017-2022)
    Figure 52. Bayer Revenue Growth Rate in Ischemic Stroke Drugs Business (2017-2022)
    Figure 53. Biogen Revenue Growth Rate in Ischemic Stroke Drugs Business (2017-2022)
    Figure 54. Abbott Laboratories Revenue Growth Rate in Ischemic Stroke Drugs Business (2017-2022)
    Figure 55. Genentech Revenue Growth Rate in Ischemic Stroke Drugs Business (2017-2022)
    Figure 56. Daiichi Sankyo Revenue Growth Rate in Ischemic Stroke Drugs Business (2017-2022)
    Figure 57. Bottom-up and Top-down Approaches for This Report
    Figure 58. Data Triangulation
    Figure 59. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Pfizer
Merck
Boehringer Ingelheim
Sanofi
Johnson & Johnson
Bayer
Biogen
Abbott Laboratories
Genentech
Daiichi Sankyo
Frequently Asked Questions
Ischemic Stroke Drugs report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Ischemic Stroke Drugs report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Ischemic Stroke Drugs report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Aquaculture Products

The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More